https://www.pro.novartis.com/uk-en/ 2026-03-24T11:35:55+00:00 daily 1.0 https://www.pro.novartis.com/uk-en/node/6 2024-06-14T08:15:01+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/article 2024-06-17T09:01:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pcarticle 2024-10-28T10:08:46+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/hero-shape-banner 2024-06-18T08:29:26+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/hero-banner 2024-06-18T08:26:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/banner 2024-06-18T13:50:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pcbreadcrumb 2024-10-28T10:09:57+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines 2026-03-30T10:51:53+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas 2026-01-13T08:47:13+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/events 2025-11-24T08:44:43+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/resources 2025-11-24T08:50:32+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/healthcare-systems-support 2026-03-24T11:38:32+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig/dosing 2025-04-28T08:25:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/efficacy-psa 2026-02-11T08:00:35+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/qof-updates 2025-11-06T11:02:40+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/orion-8 2024-11-20T12:28:51+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/cvd-burden/ldl-c-management 2024-11-21T09:24:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/efficacy 2026-03-31T08:10:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/dosing 2026-03-31T12:58:14+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/moa 2025-01-10T10:26:26+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/safety-profile 2026-03-31T08:06:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig/contact 2025-04-28T08:46:32+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/unmet-need 2026-01-13T11:55:07+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/mechanism-of-action 2026-02-18T07:45:01+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/high-efficacy-treatment-early 2025-10-30T11:31:47+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/efficacy 2026-02-18T09:47:12+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/safety 2026-02-18T09:48:20+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/initiation-and-dosing 2026-02-18T09:49:37+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars 2025-03-05T13:21:07+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/clinical-studies 2026-02-12T11:11:22+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/contact 2026-01-15T07:56:58+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/patient-monitoring 2026-02-18T09:46:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/accessibility 2025-11-24T09:06:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/safety-profile 2026-02-12T11:15:52+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/resources 2026-03-16T12:29:14+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/terms 2025-11-24T09:02:18+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/downloadable-resources/kesimpta-switch-tool-hcp 2025-01-17T11:51:25+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/webinars 2024-11-13T09:22:53+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/downloadable-resources 2026-03-04T16:18:54+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/dosing-and-administration 2025-10-30T11:50:18+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/privacy 2025-11-24T08:52:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-test-navigation-2 2024-10-28T10:12:37+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/contact 2026-02-12T11:32:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pcproducts-test 2024-10-28T10:14:06+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/resources/sensoready-injection-video 2026-02-11T08:14:20+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/efficacy-axspa 2026-02-11T08:07:50+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-tab-test 2025-07-01T11:48:42+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-test-anchors 2024-10-28T10:15:33+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/dosing 2026-02-11T08:09:18+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/resources/unoready-injection-video 2026-02-11T08:15:07+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/resources/dosing-schedule 2026-02-11T08:13:36+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-video 2024-10-28T10:16:15+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-video-card 2024-10-28T10:16:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/pso 2026-02-10T15:34:16+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/pso/efficacy 2026-02-10T12:30:46+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/pso/dosing 2026-02-10T12:55:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/heritage 2026-02-10T14:22:52+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/mechanism-of-action 2026-02-10T14:22:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/safety-profile 2026-02-10T14:25:59+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hcp-resources 2026-02-10T12:37:04+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hcp-resources/digital-dosing-schedule 2026-02-10T12:43:41+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hcp-resources/sensoready-injection-video 2026-02-10T12:45:56+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hcp-resources/unoready-injection-video 2026-02-10T12:47:46+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hcp-resources/you-first-programme 2026-02-10T12:51:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig/efficacy 2025-04-28T08:37:13+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig/mode-of-action 2026-02-10T12:23:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig/safety-profile 2025-04-28T08:40:37+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig/resources 2025-04-28T08:44:26+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-filter 2024-07-24T10:30:12+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-qweqew 2024-10-10T10:43:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/efficacy-jia 2026-02-11T08:08:34+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/moa 2026-02-11T08:11:14+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/contact 2026-02-10T12:36:31+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/injection-demo 2025-03-05T13:25:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-video-test 2024-10-28T10:17:12+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/case-studies 2024-11-25T11:04:25+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-bootstrap 2024-10-28T10:17:36+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/contact 2026-02-11T08:15:49+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/contact 2026-02-18T09:58:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-anchor-test2 2024-10-28T10:18:40+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/resources 2026-02-11T08:13:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/safety-profile 2026-02-11T08:12:19+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-column-test 2024-10-28T10:19:12+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-bootstrap-guide 2024-10-28T10:19:37+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/myelofibrosis 2026-03-06T13:27:46+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/dosing 2026-02-11T12:20:06+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/safety-profile 2026-02-11T12:32:57+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/real-world-insights 2026-02-11T14:09:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/polycythaemia-vera 2026-02-11T14:23:12+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/resources 2026-02-10T15:41:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/resources/cpd 2026-02-10T15:42:15+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/patient-support 2024-11-07T15:21:28+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/contact 2026-02-11T14:34:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/you-first-programme 2026-02-11T08:01:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/dosing 2026-02-19T11:37:14+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/contact 2026-02-19T11:56:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/efficacy 2026-02-19T11:00:59+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/safety-profile 2026-02-19T11:30:56+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/moa 2026-02-19T11:03:08+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair/efficacy 2026-02-19T12:29:34+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair/dosing 2026-02-19T12:31:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair/qol 2026-02-19T12:32:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair/safety-profile 2026-02-19T12:38:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/prom-csu 2026-02-19T11:54:59+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/resources 2026-02-19T11:22:50+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair/selection-criteria-saa 2026-02-19T12:38:47+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair/resources 2026-03-11T16:35:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/moa 2026-02-13T10:27:27+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/efficacy 2026-02-13T10:55:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/postmenopausal-women 2026-02-13T10:56:23+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/premenopausal-women 2026-02-13T10:57:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/qol 2026-02-10T08:30:47+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/safety-profile 2026-02-13T11:17:08+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/dosing 2026-02-13T11:23:31+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/guidelines 2026-02-13T11:24:19+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/esmo 2026-02-17T09:55:30+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/nccn 2026-02-05T08:31:47+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/ecg-monitoring 2026-02-05T08:38:45+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources 2026-02-13T12:10:11+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/contact 2026-02-05T08:40:52+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/oncology/advanced-breast-cancer 2026-02-13T10:24:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-table-cells 2024-10-28T10:20:28+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-resource-cards 2024-11-12T12:49:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/oncology/advanced-breast-cancer/about-hr 2026-02-13T10:24:42+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/leqvio-in-practice/starting-in-pc 2024-11-22T09:43:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/webinars 2026-03-02T10:54:37+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/resources 2026-03-26T11:17:43+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/leqvio-in-practice/starting-in-sc 2024-11-22T10:26:35+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/cvd-burden/secondary-care-pathway 2024-11-21T11:24:11+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/implementation 2024-11-08T15:08:13+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology/pnh-service 2026-02-13T15:41:23+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/cardio-metabolic/acd 2024-11-26T12:31:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology/pnh 2026-02-13T15:40:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/kesimptaconnect 2026-02-12T11:23:37+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/healthcare-systems-support/disease-area-resources 2025-04-28T13:03:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/healthcare-systems-support/disease-area-resources/oncology 2025-05-08T10:30:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/healthcare-systems-support/partnership/collaborative-working 2025-04-28T13:05:28+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig/dosing/injection-training-video 2025-04-28T08:26:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/efficacy 2026-02-13T14:23:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/safety 2026-02-13T14:24:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/mechanism-of-action 2026-02-13T14:27:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/dosing-and-administration 2026-02-13T14:27:51+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/healthcare-systems-support/contact 2026-01-07T15:56:16+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/mayzentconnect 2026-03-17T12:36:45+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/case-study-tool 2026-02-24T10:00:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/case-study-tool/heather 2026-02-16T07:35:14+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/case-study-tool/fatima 2026-02-16T07:37:56+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/case-study-tool/james 2026-02-16T07:38:34+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/resources 2026-02-16T07:39:23+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent/contact-us 2026-03-17T12:39:41+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology/polycythaemia-vera 2026-02-13T16:21:34+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology/polycythaemia-vera/cardiovascular-risk 2026-02-13T15:24:11+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology/polycythaemia-vera/intolerance 2026-03-25T08:39:57+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology/polycythaemia-vera/living-with-pv 2026-02-13T15:27:30+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology/polycythaemia-vera/resources 2026-02-13T15:28:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology/myelofibrosis 2026-01-21T14:17:12+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/pivotal-trials 2026-01-21T16:38:32+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/roe-kings 2025-03-05T13:44:45+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/roe-st-georges 2026-01-21T16:39:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/usage-support 2026-01-21T16:36:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/learnings-st-georges 2026-01-21T16:39:38+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/patient-exposure 2026-01-21T16:40:11+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/dmt-considerations 2026-01-21T16:47:40+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/webinars/nhs-recovery-plan 2026-01-21T16:48:08+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/kesimptaconnect/patient-perspectives-video 2026-02-12T11:26:45+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/kesimptaconnect/clinical-experience-video 2026-01-21T16:53:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/webinars/what-is-leqvio 2024-11-25T14:00:43+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/webinars/trial-data 2024-11-25T14:01:19+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/webinars/moc-lincolnshire 2024-11-25T14:01:56+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/resources/using-leqvio-video 2025-11-19T09:25:19+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/resources/moa-video 2025-11-19T07:41:16+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/resources/early-intervention-video 2025-11-19T07:42:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/fabhalta/clinical-data 2026-01-14T12:56:25+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/fabhalta/patient-support 2025-10-24T07:59:06+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/resources/autoinjector-video 2026-02-19T11:26:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair/resources/autoinjector-video 2026-02-19T12:50:31+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair/resources/self-injection-video 2026-02-19T11:29:43+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair/resources/self-injection-video 2026-02-19T12:55:19+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/sandostatin-lar/administration-video 2025-08-26T08:12:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/moa 2026-02-12T11:18:36+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/healthcare-systems-support/disease-area-resources/oncology/bc-inequalities-tool 2025-05-08T10:12:18+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/healthcare-systems-support/disease-area-resources/oncology/sim-calculator 2024-10-31T11:51:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hs 2026-02-10T12:35:34+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hs/dosing 2026-02-10T14:21:22+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimptaconnect/supporting-patients-video 2026-02-12T11:25:27+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hs/efficacy 2026-02-10T12:58:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hs/qol 2026-02-10T12:59:40+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-list-test-2410 2025-06-23T15:02:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-product-stream-test 2024-10-28T10:24:06+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/efficacy 2025-12-22T07:56:03+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/moa/ms-pathogonesis-video 2026-02-12T11:19:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/moa/mechanism-video 2026-02-12T11:22:26+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/moa 2026-02-11T08:22:43+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/moa 2025-07-29T13:41:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/efficacy 2025-05-08T14:10:40+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/efficacy/combi-v-and-combi-d 2026-02-19T10:35:22+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/efficacy/combi-ad 2025-07-29T10:11:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/safety 2025-07-29T10:17:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/safety/combi-v-and-combi-d 2025-05-09T06:51:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/management 2025-07-29T09:11:23+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/management/dosing 2025-05-08T15:45:30+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/contact 2025-05-08T14:34:22+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/diagnosis-and-treatment 2025-05-08T13:16:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-nosnippet-test 2025-07-01T12:46:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/safety/combi-ad 2025-05-08T14:26:16+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma/management/dose-modifications 2025-05-08T14:33:23+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/node/2156 2025-04-28T12:47:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/clone-pc-anchor-test2 2024-11-29T12:55:53+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-popup-test 2024-11-29T16:19:55+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/dosing-and-administration/injection-demo 2026-01-21T16:56:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/safety-profile 2026-02-11T08:46:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/dosing 2026-02-11T08:23:27+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/contact 2026-02-11T09:17:08+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/treatment-goals-video 2026-02-05T08:41:49+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/lung-cancer/safety-profile 2026-02-18T11:14:51+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/overall-survival 2026-02-05T08:26:48+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/visceral-metastases 2026-02-13T11:10:53+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc/older-patients 2026-02-13T10:46:29+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/ebc/safety-profile 2026-02-13T10:47:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/lung-cancer/braf-moa 2026-02-18T11:08:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/lung-cancer/dosing 2026-02-18T11:15:45+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/efficacy 2026-02-11T08:40:42+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/lung-cancer/efficacy 2026-02-18T11:10:59+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/healthcare-systems-support/business-case-support/dermatology-and-rheumatology 2026-01-22T15:33:45+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/rwe 2026-02-11T08:45:54+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-new-features-90 2025-07-09T13:55:07+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology/llaris/contact-us 2026-01-22T15:20:16+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/dosing/rwe 2026-02-11T08:10:03+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-test-product-cards 2025-02-06T11:14:43+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-2-col-test 2025-12-01T09:13:06+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology/ilaris/safety-profile 2026-02-11T10:40:36+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology/ilaris/safety-profile/pfs 2026-02-11T11:26:46+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology/ilaris/safety-profile/stills 2026-02-11T11:35:27+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology/llaris/resources-for-hcps 2026-02-11T10:01:15+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology/llaris/resources-for-hcps-to-give-to-patients 2026-02-11T11:02:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/immunology/periodic-fever-syndromes 2026-02-13T10:11:28+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/immunology/periodic-fever-syndromes/fmf 2026-02-13T10:50:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/jr-test-article 2026-01-08T11:22:48+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/perspective-on-kisqali-video 2026-02-05T08:42:25+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/pso/rwe 2026-02-10T12:56:47+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/patient-case-studies 2026-02-12T11:05:19+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/myentresto 2026-02-11T09:14:14+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/cardio-metabolic/heart-failure 2026-02-13T10:30:48+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/guidelines 2026-02-11T09:16:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-switch 2025-04-17T09:22:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-features 2026-01-29T09:21:11+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology/ilaris/efficacy 2026-02-11T11:39:12+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-quiz-test 2025-10-01T14:11:52+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-area/dermatology/xolair/xolair-e-learning-home/xolair-e-learning-1 2025-05-27T10:55:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-area/dermatology/xolair/xolair-e-learning-home/xolair-e-learning-2 2025-05-27T10:56:52+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/disease-burden-psa 2026-02-11T08:02:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/pso/patient-impact 2026-02-10T12:53:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/pso/patient-management 2026-02-10T12:54:55+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/sams-test 2026-02-24T14:03:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/dosing-calc 2025-07-10T12:51:25+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/kisqali-eligiblity-calculator 2025-07-25T13:07:28+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-video-speed-test 2025-06-23T12:51:04+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-calender 2025-06-24T09:29:08+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/sh-test-article 2026-03-19T09:42:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/dosing/ebc-eligibility-tool 2026-01-23T12:38:50+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/prof-peter-fasching-patient-case-study 2026-02-13T12:10:49+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/mda 2026-02-11T08:02:52+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/dr-caroline-michie-patient-case-study 2026-02-13T12:26:48+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/dr-mark-verrill-patient-case-study 2026-02-13T12:27:26+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/ebc/patient-eligibility 2026-03-10T09:04:50+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/ebc/efficacy 2026-02-13T10:47:45+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-tab-map 2025-07-10T07:42:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/dr-mark-tuthill-patient-case-study 2026-02-13T12:28:31+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/dr-alastair-thomson-patient-case-study 2026-02-13T12:29:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/bleddyn-edwards-patient-case-study 2026-02-13T12:30:01+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/case-studies 2026-03-25T11:41:30+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/abc 2026-02-13T10:26:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/ebc 2026-02-13T11:00:12+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/interstellar2025 2025-07-31T12:30:33+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/another-nicki-test 2026-03-24T14:02:46+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/pluvicto/clinical-trials 2026-02-17T09:40:42+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/pluvicto/safety 2026-03-25T14:14:27+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/pluvicto/dosing-and-administration 2026-02-26T14:34:07+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/pluvicto/moa 2026-03-26T11:06:37+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/pluvicto/resources 2026-03-26T11:00:01+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/pluvicto/contact-us 2026-03-25T14:13:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/nets-treatment 2026-02-09T14:33:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/identifying-progression 2026-02-09T14:32:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/netter-1 2026-02-09T14:31:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/netter-1/overall-survival 2025-10-27T12:51:14+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/netter-1/early-intervention 2025-10-27T13:08:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/netter-1/qol 2025-10-27T13:25:15+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/safety-profile 2026-02-09T14:30:45+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/dosing 2026-02-09T14:22:55+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/moa 2026-02-09T14:22:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/resources 2025-10-29T10:00:34+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/contact-us 2026-02-09T14:19:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera/guidelines 2026-02-09T14:20:04+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand 2026-03-25T14:41:36+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/splenomegaly 2026-02-11T14:10:08+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/radioligand/neuroendocrine-tumours 2026-02-13T10:49:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/mf-symptom-control 2026-02-10T15:35:58+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/overall-survival 2026-02-11T14:15:58+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/rwe 2025-10-30T16:49:07+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/roe 2025-10-30T12:11:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/moments-of-hope 2026-01-21T15:02:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-video-test2 2025-10-08T12:10:57+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/radioligand/prostate-cancer 2026-02-17T09:51:00+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/radioligand/scanning-for-psma 2026-02-17T09:51:49+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/resources/radioligand/science-of-rlt 2026-03-12T12:42:03+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/resources/radioligand/rlt-services 2026-03-12T12:37:38+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/resources/radioligand/rlt-services/manufacturing-and-logistics 2026-03-10T07:43:50+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/clone-pc-tab-test 2025-10-03T10:47:29+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/vap-clinic-video 2026-02-13T12:31:46+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/4-year-outcomes-video 2026-02-05T08:47:06+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/risk-of-recurrence-video 2026-02-05T08:46:31+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/copy-nicki-map-test-180925 2026-01-21T11:47:24+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi/resources/living-with-mpn-video 2026-02-11T14:24:47+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/frailty-assessment-video 2026-02-05T08:48:18+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-favourite 2025-10-29T13:04:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-filter-2 2026-02-20T10:24:59+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx/hcp-resources/dr-abduallah-case-studies 2026-02-10T12:50:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/ebc/natalee-5-year-analysis 2026-02-13T11:01:23+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/master-news-wave-3 2026-03-23T07:59:01+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/ebc/3-year-treatment-video 2026-02-13T11:07:51+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/resources 2026-03-02T10:40:22+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/resources/webinars/chronic-hf 2026-03-26T14:03:22+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/resources/webinars/optimising-hf-treatment 2026-03-26T14:23:42+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto/resources/webinars/renal-function-hf 2026-03-26T09:20:33+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/webinars/case-study-2 2026-02-27T12:14:41+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/webinars/case-study-1 2026-02-27T12:12:25+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/webinars/panel-discussion 2026-02-27T12:15:53+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/resources/webinars 2026-02-27T12:10:33+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pr-release-18 2025-12-16T10:16:27+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/neuroscience/mcdonald-criteria-ms 2026-02-13T11:10:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/heading-examples 2025-12-17T10:19:33+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx/comorbidities 2026-02-11T08:06:56+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news-wave2 2026-03-30T14:19:34+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/when-to-switch-tki/cml-sun 2026-02-18T09:39:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix/qol 2026-02-19T14:03:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-pres-viewer 2026-01-22T09:02:20+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/dermatology/csu 2026-03-23T11:24:10+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/resources/dermatology/csu-on-demand-videos 2026-03-19T15:18:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/events/dermatology/csu 2026-03-19T16:10:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/dermatology/csu/contact 2026-03-19T14:34:47+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/resources/different-by-design 2026-02-27T09:23:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pr-reels 2026-01-22T09:19:50+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-web-shopppe 2026-02-19T15:51:43+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/ai-ageing-clocks 2026-03-30T14:22:20+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/bmi-childhood-obesity 2026-03-25T07:51:22+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/financial-mental-support 2026-03-25T07:55:23+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/minorities-health-underreporting 2026-03-30T14:23:59+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/greenness-exposure 2026-03-30T14:28:44+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/impact-eating-disorders 2026-03-25T10:57:21+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/patient-fitness-surgery 2026-03-30T14:35:36+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/instability-foster-care 2026-03-25T11:53:02+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/child-mental-health 2026-03-25T12:09:08+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/life-satisfaction-model 2026-03-25T12:12:54+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/healthy-life-expectancy 2026-03-30T14:37:06+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/mothers-mental-health 2026-03-25T12:34:37+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/endometriosis-trauma 2026-03-25T12:45:42+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/ai-healthcare-guidelines 2026-03-25T14:07:57+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/remote-medical-procedures 2026-03-25T14:12:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/autism-transgender-health 2026-03-25T14:16:47+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/paediatric-staff-wellbeing 2026-03-30T14:37:50+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/smoking-cognitive-decline 2026-03-25T14:34:58+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/doctors-living-working 2026-03-25T14:47:26+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/hospital-discharge-summaries 2026-03-25T14:58:22+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/hcp-burnout-interventions 2026-03-25T15:03:33+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/sleep-disorder-monitoring 2026-03-25T15:05:50+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/alcohol-app-success 2026-03-25T15:07:59+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/food-insecurity 2026-03-25T15:10:11+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/child-hospital-mealtimes 2026-03-25T15:14:52+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/tantrums-adhd 2026-03-25T15:17:05+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/weight-gain-pregnancy 2026-03-25T15:22:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/mental-health-service-usage 2026-03-25T15:26:09+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/underweight-children-cost 2026-03-25T15:31:49+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/news/virtual-ward-carbon 2026-03-25T15:40:39+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali/ebc/qol 2026-03-27T15:00:59+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/public/medicines/neuroscience/kesimpta/patient-resources 2026-03-31T13:02:17+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/pc-2nd-july 2025-09-01T11:00:55+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/novartis-promotional-webinar-pnh-one-year 2025-09-30T08:45:53+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/london-event 2025-09-18T13:55:23+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pceventwith-sidebar 2026-01-14T08:38:17+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/cosentyx-rheum-bsr-events-page-hcp 2026-03-24T15:24:48+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/dermatology-connect-2026-event 2026-03-24T15:22:21+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta/events/nexus-26 2026-03-26T13:43:47+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/node/36 2026-03-12T04:48:33+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/node/41 2024-06-14T08:13:59+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/node/46 2025-09-29T10:34:37+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/node/71 2025-11-10T10:17:02+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pc-events 2024-06-20T11:54:22+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pc-landing-page 2024-10-28T10:25:28+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/cardio-metabolic 2026-01-22T16:34:09+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pctraning-lp-hcp 2024-10-28T10:25:54+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/cell-and-gene 2025-08-05T10:00:00+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology 2025-11-24T11:03:55+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology 2026-01-07T09:05:11+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience 2025-11-24T11:02:39+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology 2025-11-24T11:02:01+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/ophthalmology 2025-08-05T10:01:32+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology 2025-11-24T11:03:04+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory 2025-11-24T11:05:45+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology 2025-11-24T11:07:17+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/oncology 2026-01-22T16:20:09+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/ne-landing-page-test 2026-03-10T10:49:32+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/dermatology 2026-03-24T09:55:06+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/cell-and-gene 2025-08-05T10:04:56+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/haematology 2026-01-22T16:25:14+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/neuroscience 2026-01-22T16:06:18+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/ophthalmology 2025-08-05T10:05:47+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/immunology 2026-01-22T16:23:30+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/respiratory-and-inflammation 2026-01-22T16:14:58+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/rheumatology 2026-01-22T16:16:53+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic 2025-11-24T09:45:52+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/jacquis-test-page 2025-05-15T13:41:59+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pc-landing-page-0 2025-04-24T12:57:15+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/paywall 2026-02-24T14:47:29+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-area/dermatology/xolair 2025-05-27T10:52:40+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-area/dermatology/xolair/xolair-e-learning-home 2025-05-29T08:26:06+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/sh-landing-page-test 2025-06-20T13:46:03+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pc-test-lp-again 2025-08-18T10:32:42+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas/radioligand 2026-02-27T10:07:37+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pc-event-listing 2025-09-10T19:54:50+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pc-video-banner 2025-09-08T08:52:41+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/news-landing-page 2025-11-11T09:05:44+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/clone-pc-event-listing 2026-01-09T09:03:38+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/therapy-areas-landing 2026-02-19T08:55:29+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pc-landing-page-test 2026-02-27T09:16:52+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events-landing 2026-03-20T08:58:13+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/ne-product-filter-test 2026-02-26T08:17:55+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/cardio-metabolic 2026-03-18T11:42:09+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/dermatology 2026-03-18T11:43:48+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources-landing 2026-03-18T14:42:17+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/haematology 2026-03-03T08:33:39+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/immunology 2026-03-03T10:24:40+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/neuroscience 2026-03-18T16:22:02+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/oncology 2026-03-18T11:52:22+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/radioligand 2026-03-26T15:26:05+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/respiratory 2026-03-18T09:20:17+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/resources/rheumatology 2026-03-18T09:30:38+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/cardio-metabolic 2026-03-18T14:43:40+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/dermatology 2026-03-18T14:44:07+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/haematology 2026-03-18T14:44:31+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/immunology 2026-03-18T14:45:00+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/neuroscience 2026-03-18T14:45:33+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/oncology 2026-03-18T14:46:01+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/radioligand 2026-03-26T14:49:46+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/respiratory 2026-03-18T14:47:49+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/events/rheumatology 2026-03-18T14:48:13+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/leqvio 2025-09-03T02:06:53+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio 2026-03-31T08:03:44+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/respiratory/xolair 2026-02-19T12:16:37+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pchero-product 2025-09-03T02:06:53+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/cosentyx 2026-03-18T10:49:46+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/dermatology/xolair 2026-02-19T11:00:00+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/jakavi 2026-02-11T12:16:07+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig 2026-02-10T12:19:41+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/kesimpta 2026-01-12T10:04:10+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/neuroscience/mayzent 2026-02-13T14:16:33+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/kisqali 2026-02-13T10:59:09+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/lung-cancer 2026-02-18T11:04:02+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/sandostatin-lar 2025-09-03T02:06:53+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/oncology/tafinlar-mekinist/melanoma 2025-09-03T02:06:53+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/fabhalta 2025-09-03T02:06:53+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/immunology/ilaris 2026-02-11T10:00:14+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/rheumatology/cosentyx 2026-02-11T07:59:41+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/pc-test-navigation-1 2025-09-03T02:06:53+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/haematology/scemblix 2026-02-18T09:39:08+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/entresto 2026-02-11T08:21:44+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/pluvicto 2026-03-25T14:44:54+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/medicines/radioligand/lutathera 2026-03-09T14:05:05+00:00 daily 0.5 https://www.pro.novartis.com/uk-en/nicki-webshop-resource-test 2026-02-19T15:43:32+00:00 hourly 0.5 https://www.pro.novartis.com/uk-en/sitemap.xml 2026-03-31T02:38:42+00:00